Emglif (10mg) 28s Tablets
Empagliflozin 10mg tablets for type 2 diabetes.
Emglif (10mg) contains empagliflozin, an SGLT2 inhibitor that increases urinary glucose excretion. It is used for type 2 diabetes as monotherapy or in combination with other antidiabetic agents. May offer cardiovascular and renal benefit in indicated patients. Take once daily as directed.
Purpose
Treatment of type 2 diabetes mellitus as monotherapy or in combination with other antidiabetic agents.
Ingredients
Empagliflozin 10mg per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of genital and urinary infections.
Side Effects
Urinary tract infections, genital mycotic infections, volume depletion, nausea. Rare: ketoacidosis. Report unusual tiredness or abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Genix |
| Status | Active |